CRIS Current Research Information System

FAENZA, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.018
EU - Europa 3.110
AS - Asia 785
AF - Africa 230
SA - Sud America 15
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.171
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.007
GB - Regno Unito 763
IT - Italia 636
SE - Svezia 505
DE - Germania 451
CN - Cina 358
VN - Vietnam 203
IN - India 165
UA - Ucraina 138
IE - Irlanda 132
RU - Federazione Russa 105
FR - Francia 104
TG - Togo 104
ZA - Sudafrica 65
EE - Estonia 61
BG - Bulgaria 48
NG - Nigeria 38
FI - Finlandia 30
HR - Croazia 29
BE - Belgio 26
CH - Svizzera 18
AT - Austria 15
JO - Giordania 15
CI - Costa d'Avorio 12
CA - Canada 11
GR - Grecia 11
SC - Seychelles 10
BR - Brasile 8
JP - Giappone 8
RO - Romania 8
IR - Iran 7
NL - Olanda 7
NZ - Nuova Zelanda 7
ES - Italia 5
TR - Turchia 5
AU - Australia 4
LB - Libano 4
MY - Malesia 4
BD - Bangladesh 3
DK - Danimarca 3
HU - Ungheria 3
LU - Lussemburgo 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
HK - Hong Kong 2
IL - Israele 2
PE - Perù 2
RS - Serbia 2
SG - Singapore 2
AR - Argentina 1
BO - Bolivia 1
EC - Ecuador 1
EG - Egitto 1
IQ - Iraq 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 8.171
Salva come PNG Salva come JPEG
Città #
Southend 691
Fairfield 563
Chandler 490
Ashburn 347
Woodbridge 250
Ann Arbor 248
Houston 233
Wilmington 218
Seattle 211
Bologna 207
Cambridge 196
Princeton 177
Dublin 132
Dong Ket 126
Lomé 104
Jacksonville 78
Westminster 77
Nanjing 69
Padova 64
New York 59
Florence 53
Sofia 48
San Diego 45
Berlin 41
Saint Petersburg 41
Beijing 40
Abeokuta 37
Frankfurt am Main 37
Jinan 34
Forlì 31
Nanchang 31
Helsinki 28
Shenyang 28
Brussels 26
Milan 23
Boardman 22
Hebei 22
Mülheim 20
Des Moines 18
Turin 18
Medford 17
Norwalk 17
Redwood City 17
Amman 14
Changsha 14
Dearborn 14
Locri 14
Redmond 14
Abidjan 12
Bern 12
Bremen 12
Haikou 12
Jiaxing 12
Cesena 11
Ravenna 11
Rome 11
Verona 11
Vienna 11
Falls Church 9
Guangzhou 9
Mahé 9
Mountain View 9
Pune 9
San Francisco 9
Hefei 8
Ningbo 8
Tianjin 8
Zhengzhou 8
Olalla 7
Paris 7
Tokyo 7
Toronto 7
Hangzhou 6
Lanzhou 6
London 6
São Paulo 6
York 6
Buffalo 5
Chicago 5
Cunevo 5
Fuzhou 5
Kunming 5
Rimini 5
San Venanzo 5
Trento 5
Udine 5
Washington 5
Amsterdam 4
Bühl 4
Kemerovo 4
Kuala Lumpur 4
Kuban 4
Modena 4
Parma 4
Plauen 4
Taiyuan 4
Tappahannock 4
Battipaglia 3
Budapest 3
Cedar Knolls 3
Totale 5.662
Salva come PNG Salva come JPEG
Nome #
A role for PKCepsilon during C2C12 myogenic differentiation 185
Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. 164
Inositide-Dependent Nuclear Signalling in Health and Disease 154
Nuclear inositide signaling and cell cycle 152
BMP-2 Induced Expression of PLCβ1 That is a Positive Regulator of Osteoblast Differentiation 149
Nuclear phosphoinositides: Their regulation and roles in nuclear functions 149
Inositide signaling in the nucleus: From physiology to pathology. 136
Revisiting nuclear phospholipase C signalling in MDS 132
PLC-β1 and cell differentiation: An insight into myogenesis and osteogenesis 130
Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders 130
Cell cycle arrest and apoptosis induced by kinamycin f in human osteosarcoma cells 126
Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes 125
Nuclear phospholipase C β1 signaling, epigenetics and treatments in MDS 125
A role for PKR in hematologic malignancies 125
AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity 123
eEF1A phosphorylation in the nucleus of insulin-stimulated C2C12 myoblasts: Ser53 is a novel substrate for protein kinase C βI 122
Intranuclear 3'-phosphoinositide metabolism and Akt signaling: New mechanisms for tumorigenesis and protection against apoptosis? 121
Nuclear phospholipase C beta1 and cellular differentiation. 117
Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress 117
K562 cell proliferation is modulated by PLCbeta1 through a PKCalpha-mediated pathway 115
Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. 112
IPMK and β-catenin mediate PLC-β1-dependent signaling in myogenic differentiation 111
A role for PLCbeta1 in myotonic dystrophies type 1 and 2. 110
Nuclear inositide signaling in myelodysplastic syndromes. 109
Nuclear inositide specific phospholipase C signalling - interactions and activity 108
Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. 108
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. 108
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 107
Physiology and pathology of nuclear phospholipase C beta1 106
Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia 103
Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter 102
Modulation of nuclear PI-PLCbeta1 during cell differentiation 100
The physiology and pathology of inositide signaling in the nucleus 99
Increased transcription of mitochondrial genes for Complex I in human platelets during ageing 98
Phospholipase C-β1 interacts with cyclin E in adipose- derived stem cells osteogenic differentiation 98
Expression of the double-stranded RNA-dependent kinase PKR influences osteosarcoma attachment independent growth, migration, and invasion 97
Nuclear PI-PLCβ1 and Myelodysplastic Syndromes: Genetics and Epigenetics 96
Subnuclear localization and differentiation-dependent increased expression of DGK-zeta in C2C12 mouse myoblasts. 94
Lamin A and prelamin A counteract invasiveness of osteosarcoma cells 94
Metabolism and signaling activities of nuclear lipids 93
Exploring the controversial role of PI3K signalling in CD4+ regulatory T (T-Reg) cells 92
Quantitative profiling of the endonuclear glycerophospholipidome of murine embryonic fibroblasts 90
Role of nuclear PLC and PI3K signaling in the development of cancer 90
Phosphoinositide-specific Phospholipase C β 1b (PI-PLCβ1b) Interactome: Affinity Purification-Mass Spectrometry Analysis of PI-PLCβ1b with Nuclear Protein 89
Epigenetic regulation of nuclear PLCbeta1 and Cyclin D3 during Azacitidine treatment 89
MiRNA-210: A Current Overview 89
Nuclear phospholipase C beta1 (PLCbeta1) affects CD24 expression in murine erythroleukemia cells 87
PI-PLCβ1b affects Akt activation, cyclin E expression, and caspase cleavage, promoting cell survival in pro-B-lymphoblastic cells exposed to oxidative stress 87
Identification of the PKR Nuclear Interactome Reveals Roles in Ribosome Biogenesis, mRNA Processing and Cell Division 87
Therapeutic potential of nvp-bkm120 in human osteosarcomas cells 87
Recent advances in MDS mutation landscape: Splicing and signalling 87
K562 cell proliferation is modulated by PLCβ1 through a PKCα-mediated pathway 86
Nuclear phospholipase C: involvement in signal transduction 86
Nuclear PI-PLCβ1: An appraisal on targets and pathology 84
PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells 84
PLCβ1a and PLCβ1b Selective Regulation and Cyclin D3 Modulation Reduced by Kinamycin F During K562 Cell Differentiation 83
Signal transduction within the nucleus: Revisiting phosphoinositide inositide-specific phospholipase Cbeta(1). 81
Prohibitin 2 represents a novel nuclear AKT substrate during all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. 81
Mass spectrometry-based identification of Y745 of Vav1 as a tyrosine residue crucial in maturation of acute promyelocytic leukemia-derived cells 81
Nuclear inositide signaling: An appraisal of phospholipase C beta1 behavior in myelodysplastic and leukemia cells 81
null 80
Identification of nuclear substrates of Akt/PKB by functional proteomics: prohibitin 2 is a target of Akt phosphorylation in human promyelocytic leukemia cells 80
Nuclear PLCbeta1 is required for 3T3-L1 adipocyte differentiation and regulates expression of the cyclin D3-cdk4 complex. 78
null 78
Phosphoinositide 3 Kinase signaling in human stem cells from reprogramming to differentiation: A tale in cytoplasmic and nuclear compartments 77
Phosphoinositide-specific phospholipase C beta1 signal transduction in the nucleus. 75
null 74
Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling. 74
Signal transduction in ribosome biogenesis: A recipe to avoid disaster 73
Three-dimensional virtual anatomy as a new approach for medical student’s learning 73
Proteomic-based analysis of nuclear signaling: PLCbeta1 affects the expression of the splicing factor SRp20 in Friend erythroleukemia cells. 70
Phosphatidylinositol 5 phosphate (Pi5p): From behind the scenes to the front (nuclear) stage 69
Nuclear phospholipase Cβ1 interactome: a morphological and proteomic approach 68
null 65
Nuclear PLCs affect insulin secretion by targeting PPARgamma; in pancreatic beta cells. 64
null 62
Glycogen synthase kinase (GSK)-3 and the double-strand RNA-dependent kinase, PKR: When two kinases for the common good turn bad 62
Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation 61
IPMK and β-catenin take part in PLC-β1-dependent signaling pathway during myogenic differentiation 58
null 53
Combined Treatment with PI3K Inhibitors BYL-719 and CAL-101 Is a Promising Antiproliferative Strategy in Human Rhabdomyosarcoma Cells 48
Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches. 48
Morpho-functional analyses reveal that changes in the chemical structure of a marine bisindole alkaloid alter the cytotoxic effect of its derivatives 46
Phosphatidylinositol Turnover and Receptors 40
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-ss1: a central intermediary in nuclear lipid-dependent signal transduction 37
Nuclear phosphoinositides: location, regulation and function. 36
How inflammation pathways contribute to cell death in neuro-muscular disorders 35
Extra Virgin Olive Oil (EVOO), a Mediterranean Diet Component, in the Management of Muscle Mass and Function Preservation. 35
Up-regulation of nuclear PLCβ1 in myogenic differentiation 34
The Cytotoxic Effect of Curcumin in Rhabdomyosarcoma Is Associated with the Modulation of AMPK, AKT/mTOR, STAT, and p53 Signaling 27
Revisiting the role of GSK3, a modulator of innate immunity, in idiopathic inclusion body myositis 27
Innate Immunity: A Balance between Disease and Adaption to Stress 21
Prohibitin 2: At a communications crossroads 21
Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing 17
Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells. 16
Nuclear phospholipase C in biological control and cancer 16
The Inca collection (13th-15th century AD) from the Boccolari-Parenti collection (Modena, Italy): Preliminary bioanthropological and paleopathological analyses 15
Paradigm Shift in Gastric Cancer Prevention: Harnessing the Potential of Aristolochia olivieri Extract 14
Emerging role for PLCβ1 MiRNA and disease 13
Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology. 13
Totale 8.424
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.752
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019118 0 0 0 0 0 0 0 0 0 0 42 76
2019/20202.135 283 49 17 102 198 191 282 291 343 157 111 111
2020/20211.030 232 77 73 50 22 48 9 66 99 49 49 256
2021/20221.862 173 37 122 134 147 92 48 123 73 291 312 310
2022/20232.034 237 252 131 256 174 173 115 98 324 48 129 97
2023/2024710 33 126 48 66 75 151 40 47 21 51 52 0
Totale 8.437